Table 1 Clinical and pathological characteristics of the enrolled GBM patients at baseline
Characteristic | GBM only | GBM plus non-CNS tumor | P value |
|---|---|---|---|
Age (years) | |||
 Median | 53.50(34–84) | 56.00(12–76) | 0.002 |
Gender | |||
 Total | 112 | 45 | 0.000 |
 Female | 41 36.6% | 35 77.8% | |
 Male | 71 63.4% | 10 22.2% | |
OS (days) | |||
 Total | 99 | 45 | 0.177 |
 Mean rank | 69.33 | 79.47 | |
TERT status | |||
 Total | 66 | 38 | 0.034 |
 Mutant | 31 47.00% | 26 68.40% | |
 Wild type | 35 53.00% | 12 31.60% | |
MGMT promoter status | |||
 Total | 68 | 34 | 0.257 |
 Methylation | 26 38.20% | 17 50.00% | |
 Non-methylation | 42 61.80% | 17 50.00% | |
Censor | |||
 Total | 108 | 45 | 0.946 |
 Alive | 75 69.40% | 31 68.90% | |
 Dead | 33 30.60% | 14 31.10% | |